Your path to business agility
There is a significant transformation underway in the clinical research organization (CRO) space. The CRO market revenue amounts to approximately $30 billion, which is primarily generated from its core business of conducting clinical trials required for drug market admission by regulatory authorities like the United States Food and Drug Administration (FDA) and the European Medicines...
Here is an uncomfortable reality in all but the smallest firms during their R&D portfolio management processes: Between the staff running each R&D initiative and the executives making project and portfolio decisions, there’s usually a division. Maybe it’s the gap between headquarters and lab, upstairs/downstairs, east coast/west coast, London/Singapore, or even a generation gap. At...
As we start the fourth quarter, having just come back from the annual Association for Financial Professionals (AFP) national conference, it seems like an appropriate time to reflect on the trends of the last year. Read on for seven financial planning and analysis trends from 2012. Trend #1: The Rise of FP&A Within the finance...
In the words of one of baseball’s brightest stars Yogi Berra, “If you don’t know where you are going, you might wind up someplace else”. Score a win for your IT project and realize more revenue by implementing these key project management tips. Deliver projects on time, and within budget. Just put on your manager’s...
I recently attended the Optimizing Innovation Conference in NYC as Planview was a sponsor. Initially, I was surprised that half of the attendees had traveled from Europe just for a two-day conference. Once the sessions began, I quickly understood their motivation. Speakers from Levi® Strauss, NASA, MTV Networks, Goodyear®, Mozilla, Kraft, and many other companies...
Dan Smith and I have written a white paper on strategic R&D portfolio management that summarizes many of the lessons and insights we’ve gleaned during twelve years of client engagements. The white paper is organized into eight ‘rules’: Avoid incomplete strategies Build an actionable strategy Don’t buy in to bubble plots Move beyond prioritization Present...
The Product Portfolio Mavens are back and this time they’ve recorded in an undisclosed location. In addition to sharing insights on hitting launch windows and pipeline visibility, Pamela and Carrie provide an update on the PDMA PIM Conference and shed light on the latest product portfolio management rumors.
It’s no secret that projects in the earlier stages of the development lifecycle are evaluated and managed very differently than projects in the later stages. One major pharmaceutical company believed these differences to be so great, however, that they split their development organization in two. Over time, the structural gulf became a cultural gulf, leading...
By Samir Mukadam, VP of Product Management at Innotas We briefly mentioned Application Portfolio Management (APM) in our most recent post. Since then we have received many emails from customers and prospects on how one should go about rolling out APM in their organization. –Here is how Innotas thinks an IT organization should approach APM:...
Humans have always been and will always be storytellers. From the fireside tales of bygone millennia to today’s TV dramas and movies, the power of the narrative holds us in rapt attention as it both entertains and makes sense of the world around us. How does this relate to pharmaceutical portfolio management? Essentially, portfolio management...
